Parabilis Medicines PBLS
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$2.16M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 45.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 4.26% to 8.95% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +1,433,806 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,456,974 | 1.2% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +905,587 | 0.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +757,790 | 0.6% |
| FMR | Mutual Fund | 2026/Q3 | +10,292,735 | 8.3% |
| Arch Venture Partners, L.P. | VC/PE Fund | 2026/Q3 | +6,412,780 | 5.2% |
| venBio LLC | VC/PE Fund | 2026/Q3 | +5,266,697 | 4.3% |
| GV Management Company, LLC | VC/PE Fund | 2026/Q3 | +4,919,498 | 4.0% |
| Nextech Invest Ltd. | VC/PE Fund | 2026/Q3 | +4,663,176 | 3.8% |
| Cormorant Asset Management, LP | Hedge Fund | 2026/Q3 | +4,615,612 | 3.7% |
| Regeneron Pharmaceuticals, Inc. | Public Company | 2026/Q3 | +4,166,666 | 3.4% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +2,992,259 | 2.4% |
| Farallon Capital Management, L.L.C. | Hedge Fund | 2026/Q3 | +2,368,200 | 1.9% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +2,296,547 | 1.9% |
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +1,920,805 | 1.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 21 Aug 2026 | Craig Tendler | Independent Director | Other Derivative Acquisition | +20,294 | $39.36 | 20,294 |
| 21 Aug 2026 | Craig Tendler | Independent Director | Initial Statement of Beneficial | +0 | – | 16,245 |
| 21 Jul 2026 | RA Capital Management, L.P. | Open Market Acquisition | +244,593 | $30.00 | 29,177,964 | |
| 14 Jun 2026 | Apothecary Capital LLC | Open Market Acquisition | +17,500 | $27.67 | 30,000 | |
| 10 Jun 2026 | Edward Fitzgerald | Independent Director | Other Derivative Acquisition | +3,666 | – | – |
| 10 Jun 2026 | Edward Fitzgerald | Independent Director | Other Derivative Acquisition | +5,332 | – | – |
| 10 Jun 2026 | Edward Fitzgerald | Independent Director | Other Derivative Acquisition | +8,111 | – | – |
| 10 Jun 2026 | Edward Fitzgerald | Independent Director | Derivative Exercise and Retained | +14,688 | – | 14,688 |
| 10 Jun 2026 | Alexis Borisy | Independent Director | Other Derivative Acquisition | +162,221 | – | – |
| 10 Jun 2026 | Alexis Borisy | Independent Director | Derivative Exercise and Retained | +105,414 | – | 105,414 |
| 10 Jun 2026 | Deerfield Management Company, L.P. | Derivative Exercise and Retained | +1,880,704 | – | 1,880,704 | |
| 10 Jun 2026 | Apothecary Capital LLC | Private Acquisition | +12,500 | $20.00 | 12,500 | |
| 10 Jun 2026 | RA Capital Management, L.P. | Private Acquisition | +21,188,750 | $20.00 | 28,933,371 | |
| 10 Jun 2026 | RA Capital Management, L.P. | Derivative Exercise and Retained | +7,744,621 | – | 28,933,371 | |
| 10 Jun 2026 | Soleus Capital Management, L.P. | Private Acquisition | +500,000 | $20.00 | 1,027,000 | |
| 10 Jun 2026 | Soleus Capital Management, L.P. | Derivative Exercise and Retained | +527,070 | $9.48 | 1,027,000 | |
| 8 Jun 2026 | Edward Fitzgerald | Independent Director | Other Derivative Acquisition | +20,215 | $20.00 | 20,215 |
| 8 Jun 2026 | Edward Fitzgerald | Independent Director | Initial Statement of Beneficial | +0 | – | 64,980 |
| 8 Jun 2026 | Alan Sebulsky | Independent Director | Other Derivative Acquisition | +39,792 | $20.00 | 39,792 |
| 8 Jun 2026 | Alexis Borisy | Independent Director | Other Derivative Acquisition | +20,215 | $20.00 | 20,215 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 11,052,337 | 8.9% | 8.3 |
| 15 Oct 2026 | 9,250,099 | 7.5% | 9.5 |
| 30 Sep 2026 | 8,261,483 | 6.7% | 4.8 |
| 15 Sep 2026 | 6,092,212 | 4.9% | 13.3 |
| 31 Aug 2026 | 5,517,704 | 4.5% | 14.2 |
| 14 Aug 2026 | 5,257,000 | 4.3% | 15.7 |
No comments yet — be the first to weigh in on PBLS.
Sign in to join the discussion.